Searching for Solutions

Congratulations to Kelly Gable, Suzanne Harris, Kelly Lee, Rosana Steavenson, Jonathan Leung, Mary Accomando and all the other members making an impact in psychiatric pharmacy!

Welcome to our January AAPP Perspective featuring articles commissioned by our Resident and New Practitioner Committee around the topic of Diversity, Equity, and Inclusion (DEI). Since DEI is critically important and one of the primary drivers in the AAPP strategic plan, I am excited to learn from my peers who have authored featured articles.

In 2023, AAPP increased its efforts in terms of outreach and engagement with legislators, regulators, and partner organizations and weighing in on issues impacting the membership and outlined in the 2023 Health Policy Agenda. As the new year begins, we look back on the many advocacy activities AAPP was engaged in last year with the expectation that 2024 will be action packed and full of opportunity to educate and promote the vital work of psychiatric pharmacists.

Telehealth is defined by the Health Resources Services Administration as "the use of electronic information and telecommunication technologies to support long-distance clinical health care, patient and professional health-related education, health administration, and public health.” These technologies can include the internet, video conferencing, store-and-forward imaging, media streaming, and land and wireless communications.1

Congratulations to Jennifer Bean, Julie Dopheide, Vicki Ellingrod, Ian McGrane and all the other members making an impact in psychiatric pharmacy!

Happy New Year and welcome to our January AAPP Perspective featuring articles commissioned by our Resident and New Practitioner Committee around the topic of Diversity, Equity, and Inclusion (DEI). Take this opportunity to learn from your peers as well as hear from AAPP President Amy Werremeyer about AAPP's top 5 mission critical AAPP New Year’s resolutions for 2024.

We are thrilled to announce the 2024 Annual Meeting, scheduled for April 7-10, 2024, at the Omni Orlando Resort at ChampionsGate, a secluded oasis situated perfectly southwest of downtown Orlando. The Omni Orlando provides a secluded resort environment perfect for education and networking. AAPP 2024 is a perfect opportunity to refocus on your career, connect with colleagues, and to come away refreshed with tangible practice ideas and recommendations.

AAPP is proud to host psychiatric pharmacists, psychiatric pharmacy residents, and pharmacy students of diverse races, ethnicities, religions, genders, and sexual orientations at AAPP 2024. AAPP understands how the environment in the host state of Florida may be concerning to conference registrants and members and, as such, AAPP has taken many steps to prioritize the attendee experience and wellbeing.

We are in the process of upgrading our online commerce. Unfortunately, you have found a link that still points to the old system. The link has been sent to the office, so the situation should be corrected soon. Please check back in a few days, send your contact information to the office, or consider registering via mail. Thank you for your patience!

A burgeoning mental health crisis is evident in the United States, despite the country’s dedication of significant human resources and spending on mental health care and research. Effectively responding to this crisis is impeded by the dominant framing of mental ill health through the prism of diagnostic categories, leading to an excessive reliance on pharmacological interventions that are delivered by specialists.

Anxiety disorders share features of persistent and excessive worry and can interfere with many daily activities. Approximately 19.1% of United States adults had an anxiety disorder in the past year and the lifetime prevalence is as high as 31%. Anxiety disorders are often treated with medication, psychotherapy, or a combination of both.

Outside of conversations around suicide, disease progression, death, and dying are not commonly discussed in psychiatric practice. Palliative care for patients with mental illness is not typically considered beyond the context of terminal medical illness.

Are you a pharmacist, practitioner, scientist, administrator, physician or nurse practitioner? You may find great value in a AAPP membership. You can explore the benefits of membership or join now and experience them yourself.

In an era where technology is a necessary part of our day-to-day, it often feels like we can’t thrive without our phone and the many applications that make it personal to us. Thanks to digital therapeutics (DTx), phones have become an important component of treatment. Mental health DTx are application-based programs which aid patients in navigating treatment for their mental health disorder(s).

Customized, Energizing, Unique, Targeted—these are all adjectives used to describe the AAPP Annual Meeting. The opportunity to participate in this high quality, practical event is now available for 2024.

Psychiatric pharmacists require comprehensive knowledge not only in psychiatry and neurology but also proficiency in clinical problem solving, interprofessionalism, and communication with empathy for the patient population they serve.

Medication-induced movement disorders are a variety of iatrogenic and clinically distinct movement disorders caused by various psychiatric medications. The disordered movements can range from tremors to life-threatening syndromes. Movement disorders are classified based on the time of onset after drug ingestion (acute, subacute, or tardive), offending medication, and specific type(s) of abnormal movement. Extrapyramidal Symptoms

Insomnia American Academy of Neurology (AAN) Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder (2020) American Academy of Sleep Medicine (AASM)